Cycle Pharmaceuticals is pleased to announce that it has signed an agreement with Baylor Genetics

December 18, 2019

Emotional and behavioral problems, quality of life and metabolic control in NTBC-treated Tyrosinemia type 1 patients

December 4, 2019

http://ensemblecontrelatyrosinemie.fr/en/

The Tyrosinemia Society and the French sister society "Ensemble contre la tyrosinemie" partner to share experiences and clinical research directions.

Orphan disease treatment “at a tipping point” thanks to advances in clinical pharmacology

Diana LaChance, The University of Alabama in Huntsville

July 3, 2019